Jiangxi Provincial Cancer Hospital

This study tests whether adding toripalimab (an immunotherapy) to standard capecitabine maintenance therapy works better than capecitabine alone for people with high-risk nasopharyngeal carcinoma. About 264 participants who have completed initial chemotherapy and radiation will b…

This study tests a new treatment for people whose nasopharyngeal cancer has come back and cannot be removed with surgery. The treatment uses a special pattern of low and high dose radiation along with an immunotherapy drug (anti-PD-1) to shrink tumors while protecting healthy tis…

This study tests whether a topical chlorhexidine spray can prevent severe skin reactions caused by radiation therapy in people with nasopharyngeal cancer. About 148 participants will receive either the spray or a placebo during their radiation treatment. The goal is to see if the…